Login to Your Account

Qiagen: $39.2M For Molecular Diagnostics Firm Artus GmbH

By Cormac Sheridan

Wednesday, June 1, 2005
In a cash transaction that it said would be earnings accretive from next year, Qiagen NV is acquiring Artus GmbH for a total outlay of $39.2 million. Some $11.6 million of that will be held in escrow and released upon the achievement of performance milestones. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription